← Back to context Comment by wbl 15 hours ago Worth it 4 comments wbl Reply D-Coder 14 hours ago It's a trade-off: better info versus handling an immediate crisis. If it's not an immediate crisis, you can take more time.Engineering is trade-offs. wbl 14 hours ago People are dying of these diseases every day D-Coder 10 hours ago And killing them with an insufficiently tested treatment is not optimal. ryoshoe 14 hours ago For patients. But maybe not to the companies which would have to pay for these large expedited trials
D-Coder 14 hours ago It's a trade-off: better info versus handling an immediate crisis. If it's not an immediate crisis, you can take more time.Engineering is trade-offs. wbl 14 hours ago People are dying of these diseases every day D-Coder 10 hours ago And killing them with an insufficiently tested treatment is not optimal.
wbl 14 hours ago People are dying of these diseases every day D-Coder 10 hours ago And killing them with an insufficiently tested treatment is not optimal.
ryoshoe 14 hours ago For patients. But maybe not to the companies which would have to pay for these large expedited trials
It's a trade-off: better info versus handling an immediate crisis. If it's not an immediate crisis, you can take more time.
Engineering is trade-offs.
People are dying of these diseases every day
And killing them with an insufficiently tested treatment is not optimal.
For patients. But maybe not to the companies which would have to pay for these large expedited trials